$AXLA

Axcella Health Inc

  • NASDAQ
  • Pharmaceuticals: Major
  • Biotechnology
  • Health Technology

PRICE

$1.97 ▲0.51%

Extented Hours

VOLUME

31,193

DAY RANGE

1.94 - 1.9728

52 WEEK

1.35 - 5.9

Join Discuss about AXLA with like-minded investors

profile
@HeyShoe #droscrew
recently

RECAP 10/26 Chatter: $GME + Metaverse $PHUN - Filed 424b $OCGN - WHO Covaxin clarification $EMR - Thermo-Disc unit sale $AXLA + Long Covid treatment

93 Replies 8 👍 7 🔥

Key Metrics

Market Cap

103.05 M

Beta

1.25

Avg. Volume

26.83 K

Shares Outstanding

52.58 M

Yield

0%

Public Float

0

Next Earnings Date

2022-07-28

Next Dividend Date

Company Information

Axcella is a clinical-stage biotechnology company pioneering a new approach to treat complex diseases and improve health using endogenous metabolic modulator (EMM) compositions. The company's product candidates are comprised of EMMs and their derivatives that are engineered in distinct combinations and ratios to simultaneously impact multiple biological pathways. Axcella's pipeline includes lead therapeutic candidates for non-alcoholic steatohepatitis (NASH) and the reduction in risk of overt hepatic encephalopathy (OHE) recurrence.

Website:

HQ: ,

Related News